Home » Topics » Substance use and poisoning, BioWorld Science

Substance use and poisoning, BioWorld Science
RSS

Anti-ALDH2 gene therapy could discourage alcohol intake

Oct. 11, 2017

NIH grant supports exploration of NVP-015 for use against chemical threats

Oct. 5, 2017

Emergent BioSolutions completes acquisition of raxibacumab from GSK

Oct. 4, 2017

Opiant and Titan to develop product for opioid use disorder

Oct. 3, 2017

NIDA grant supports Camino Pharma's development of compounds for substance use disorders

Sep. 29, 2017

Aeolus Pharmaceuticals' AEOL-10150 safe and well-tolerated in phase I study

Sep. 20, 2017

Emergent Biosolutions awarded funding to develop antidote spray for cyanide poisoning

Sep. 20, 2017

FDA accepts Camurus' NDA for CAM-2038 buprenorphine depots

Sep. 19, 2017

FDA grants priority review to Braeburn's NDA for CAM-2038 for opioid use disorder

Sep. 18, 2017

CHMP adopts positive opinion for Zubsolv as treatment of opioid dependence

Sep. 18, 2017

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...